Oncology

A new partnership combines live biopsy analysis with agentic AI, seeking to predict immunotherapy response and solve why only 1 in 5 patients benefit.

Former BCBS CEO Dr. Craig Samitt joins Enlace Health's board, signaling a major push to control the high costs of specialty care with new technology.

A new oral therapy shows a 76% response rate in a hard-to-treat lung cancer, offering a powerful new first-line option for patients with this rare disease.

With founder Frédéric Mascha as Executive Chairman and new CEO Renaud Sermondade, Juvisé Pharmaceuticals is poised for major M&A-fueled global expansion.

A new Finnish startup has launched with a tech that could detect cancer years earlier by amplifying protein signals, aiming to shift healthcare to prevention.

A CEO's personal battle with prostate cancer inspired a community golf tournament that is now on the verge of raising $1 million for critical research.

Shanghai's SinoUnited Health is attracting global patients with advanced care like CAR-T therapy at a fraction of US prices, challenging medical tourism hubs.

A new fund, led by a lung cancer survivor and top radiologists, seeks to overhaul screening guidelines that currently miss thousands of at-risk patients.

A groundbreaking study using single-molecule sequencing has revealed how key proteins malfunction in cancer, paving the way for new treatment strategies.

As scientific innovation in oncology accelerates, a new bottleneck emerges: bringing discoveries to market. Specialized firms are now crucial guides.

Taiwanese biotech GlycoNex will begin human trials for GNX1021, a novel ADC that targets cancer's unique sugar coating to fight GI tumors.

Renaissance Pharma's Daretabart gains FDA support for high-risk neuroblastoma, accelerating its journey to patients and offering new hope against this rare disease.

With oral cancer on the rise, especially in younger adults, 49 surgical practices are offering free screenings. Here's why early detection is critical.

A novel drug combination shows promising early results for a deadly ovarian cancer, potentially expanding the benefit of immunotherapy to more patients.

Agamon Health's new OncoPrep tool uses 'agentic AI' to automate complex pre-visit tasks, promising faster, more coordinated cancer care.

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

New data shows first-in-class drug tegavivint successfully inhibits the Wnt pathway, a driver in 30% of solid tumors, offering hope for tough cancers.

With promising Phase 2 data for its novel peptide therapies, Sapience Therapeutics is engaging investors, signaling a critical push for future growth.

New data shows Imofinostat turns 'cold' colorectal tumors 'hot' for immunotherapy and breaks chemo-resistance in pancreatic cancer, fueling pivotal trials.

Landmark trial shows proton therapy boosts survival and cuts side effects, offering new hope as cancer rates climb in adults under 50.